COVID-19时代的小儿显微喉镜与支气管镜技术改良
该观察性病例系列描述了在澳大利亚三级小儿耳鼻咽喉科采用改良技术进行小儿显微喉镜与支气管镜检查,以减少SARS-CoV-2气溶胶传播风险。2020年3月23日至4月9日期间对8例患儿成功实施该技术,其中6例进行了介入操作,无不良事件发生。
要点
- 改良技术旨在减少呼吸道分泌物气溶胶化。
- 8例患儿中位年龄160天,技术成功用于诊断和介入操作。
- 6例介入操作包括球囊扩张、透明质酸注射和声门上成形术,无不良事件。
核心结论
- 改良的小儿显微喉镜与支气管镜技术在该病例系列中显示可行。
- 该技术可能减少围手术期和术中气溶胶化呼吸道分泌物的传播,但需进一步研究。
研究设计与样本
- 观察性病例系列,在澳大利亚三级小儿耳鼻咽喉科进行。
- 纳入2020年3月23日至4月9日期间接受紧急或急诊气道操作的8例小儿患者,中位随访24.5天(范围11-28天)。
主要发现
- 技术成功用于8例患者(中位年龄160天,范围27天至2岁6个月;5男3女)。
- 6例患者接受介入操作:2例声门下狭窄球囊扩张,2例1型喉裂透明质酸注射,2例冷钢声门上成形术。
- 无不良事件发生。
临床怎么用
- 在COVID-19时期,可考虑采用改良技术进行小儿显微喉镜与支气管镜以降低气溶胶传播风险。
- 该技术需进一步研究以确认其广泛适用性和患者结局。
局限性
- 样本量小(8例),随访时间短。
- 技术及患者结局需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: As an aerosol-generating procedure, traditional pediatric microlaryngoscopy and bronchoscopy techniques must be adapted in order to reduce the risk of transmission of severe acute respiratory syndrome coronavirus 2. OBJECTIVE: To describe a modified technique for pediatric microlaryngoscopy and bronchoscopy for use in the COVID-19 era and present a case series of patients for whom the technique has been used. DESIGN, SETTING, AND PARTICIPANTS: Observational case series of pediatric patients undergoing emergency or urgent airway procedures performed at a tertiary pediatric otolaryngology department in Australia. Procedures were completed between March 23 and April 9, 2020, with a median (range) follow-up of 24.5 (11-28) days. EXPOSURES: Modified technique for microlaryngoscopy and bronchoscopy, minimizing aerosolization of respiratory tract secretions. MAIN OUTCOMES AND MEASURES: The main outcome was the feasibility of technique, which was measured by ability to perform microlaryngoscopy and bronchoscopy with comparable success to the usual technique (ie, adequate examination of the patient for diagnostic procedures and ability to perform interventional procedures). RESULTS: The technique was used successfully in 8 patients (median [range] age, 160 days [27 days to 2 years 6 months]); 5 patients were male, and 3 were female. Intervention was performed on 6 patients; 2 balloon dilations for subglottic stenosis, 2 injections of hyaluronic acid for type 1 clefts, and 2 cold-steel supraglottoplasties. No adverse events occurred. CONCLUSIONS AND RELEVANCE: In this case series, feasibility of a modified technique for pediatric microlaryngoscopy and bronchoscopy was demonstrated. By reconsidering the surgical approach in light of specific COVID-19 infection risks, this technique may be associated with reduced spread of aerosolized respiratory secretions perioperatively and intraoperatively, but the technique and patient outcomes require further study.
引用
- Pollaers K, Herbert H, Vijayasekaran S, et al. Pediatric Microlaryngoscopy and Bronchoscopy in the COVID-19 Era. JAMA Otolaryngol Head Neck Surg. 2020. PMID: 32343300. doi:10.1001/jamaoto.2020.1191
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。